APP and Alzheimer disease: This finding mirrors findings from Alzheimer’s disease models, where amyloid precursor protein (APP)/presenilin 1 (PS1)-overexpressing microglia from mice exhibited disrupted phagocytosis and increased glycolysis [96, 97].